These materials are intended to help you understand more about cystic fibrosis (CF) and treatment with KALYDECO®.

KALYDECO—For CFTR Mutations Studied in Vitro and in Trial 7

Download to learn more about the 28 mutations approved in 2017.
Download this brochure now >>

Delivering KALYDECO to Patients as Young as 1 Year

Download this brochure for an overview of clinical trial data in patients with CF age 1 to less than 2 years.
Download this brochure now >>